These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22074627)

  • 1. Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.
    Zou T; Satake A; Ojha P; Kambayashi T
    Transfusion; 2011 Nov; 51 Suppl 4(0 4):160S-168S. PubMed ID: 22074627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.
    Gangi E; Vasu C; Cheatem D; Prabhakar BS
    J Immunol; 2005 Jun; 174(11):7006-13. PubMed ID: 15905543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
    Szabolcs P; Moore MA; Young JW
    J Immunol; 1995 Jun; 154(11):5851-61. PubMed ID: 7538534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.
    Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD
    J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-mediated communication between dendritic epidermal T cells and Langerhans cells. In vitro studies using cell lines.
    Yokota K; Ariizumi K; Kitajima T; Bergstresser PR; Street NE; Takashima A
    J Immunol; 1996 Aug; 157(4):1529-37. PubMed ID: 8759735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation.
    Min L; Mohammad Isa SA; Shuai W; Piang CB; Nih FW; Kotaka M; Ruedl C
    J Immunol; 2010 May; 184(9):4625-9. PubMed ID: 20357255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
    O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
    Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.
    Caux C; Massacrier C; Vanbervliet B; Dubois B; Durand I; Cella M; Lanzavecchia A; Banchereau J
    Blood; 1997 Aug; 90(4):1458-70. PubMed ID: 9269763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood CD34+ cells differentiate into dermal dendritic cells in co-culture with cutaneous fibroblasts or stromal cells.
    Mollah ZU; Aiba S; Manome H; Yoshino Y; Tagami H
    J Invest Dermatol; 2002 Mar; 118(3):450-60. PubMed ID: 11874484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
    O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
    Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro.
    Chen B; Shi Y; Smith JD; Choi D; Geiger JD; Mulé JJ
    Blood; 1998 Jun; 91(12):4652-61. PubMed ID: 9616162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis.
    Sheng JR; Muthusamy T; Prabhakar BS; Meriggioli MN
    J Neuroimmunol; 2011 Dec; 240-241():65-73. PubMed ID: 22099723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
    Jinushi M; Hodi FS; Dranoff G
    Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.
    Moschella F; Bisikirska B; Maffei A; Papadopoulos KP; Skerrett D; Liu Z; Hesdorffer CS; Harris PE
    Clin Cancer Res; 2003 Jun; 9(6):2022-31. PubMed ID: 12796364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
    Sallusto F; Lanzavecchia A
    J Exp Med; 1994 Apr; 179(4):1109-18. PubMed ID: 8145033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.